Negative drug results cost AbbVie billions of dollars in market value and convinced analysts that Bristol Myers had placed a ...
Store brands can save you money—and many are getting better than ever. But read the labels closely: Some aren't the bargain ...
We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...
Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its ...
The company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, ...
Bristol Myers Squibb (BMS) witnessed the largest growth in market capitalisation of 24.6% to $105bn in Q3 2024, fuelled by ...